Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Nov;81(5):874–880. doi: 10.1038/sj.bjc.6690779

HIT family genes: FHIT but not PKCI-1/HINT produces altered transcripts in colorectal cancer

J Elnatan 1, D Murphy 2, H-S Goh 1, D R Smith 1
PMCID: PMC2374304  PMID: 10555761

Abstract

Forty-five colorectal adenocarcinomas were examined for alterations in the HIT family genes FHIT and PKCI-1/HINT by a combination of reverse transcriptase polymerase chain reaction and DNA sequencing. In all cases a single transcript corresponding to the reported sequence was detected using primers specific for the PKCI-1/HINT gene. In contrast multiple transcripts were detected using primers specific for the FHIT gene transcript. 6% (3/45) of tumours evinced no detectable expression of any FHIT transcript and a further 12% (6/45) produced only the normal full length transcripts. Ninety-six aberrant transcripts were characterized from the remaining tumours. Deviations from the normal full length sequence characterized included deletions, insertions of novel sequences, a point mutation as well as the usage of a putative alternate splice site in exon 10. Message variants were detected with approximately equal frequency in all tumour stages with the exception that templates with insertions were found solely in Dukes’ stage B tumours (P < 0.001). With the exception of the putative alternate splice site, aberrant transcripts were not detected in matched normal mucosa. These results suggest that members of the HIT family of genes are only selectively involved in tumorigenesis and that perturbation of FHIT gene expression is an early event in colorectal tumorigenesis. © 1999 Cancer Research Campaign

Keywords: colorectal, tumour, transcription, HIT genes

Full Text

The Full Text of this article is available as a PDF (599.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmadian M., Wistuba I. I., Fong K. M., Behrens C., Kodagoda D. R., Saboorian M. H., Shay J., Tomlinson G. E., Blum J., Minna J. D. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res. 1997 Sep 1;57(17):3664–3668. [PubMed] [Google Scholar]
  2. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., vanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989 Apr 14;244(4901):217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  3. Bos J. L., Fearon E. R., Hamilton S. R., Verlaan-de Vries M., van Boom J. H., van der Eb A. J., Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. 1987 May 28-Jun 3Nature. 327(6120):293–297. doi: 10.1038/327293a0. [DOI] [PubMed] [Google Scholar]
  4. Bronner C. E., Baker S. M., Morrison P. T., Warren G., Smith L. G., Lescoe M. K., Kane M., Earabino C., Lipford J., Lindblom A. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994 Mar 17;368(6468):258–261. doi: 10.1038/368258a0. [DOI] [PubMed] [Google Scholar]
  5. Brzoska P. M., Chen H., Zhu Y., Levin N. A., Disatnik M. H., Mochly-Rosen D., Murnane J. P., Christman M. F. The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7824–7828. doi: 10.1073/pnas.92.17.7824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen Y. J., Chen P. H., Lee M. D., Chang J. G. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract. Int J Cancer. 1997 Sep 17;72(6):955–958. doi: 10.1002/(sici)1097-0215(19970917)72:6<955::aid-ijc6>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  7. Chew L. J., Murphy D., Carter D. A. Alternatively polyadenylated vasoactive intestinal peptide mRNAs are differentially regulated at the level of stability. Mol Endocrinol. 1994 May;8(5):603–613. doi: 10.1210/mend.8.5.7520128. [DOI] [PubMed] [Google Scholar]
  8. Cohen A. J., Li F. P., Berg S., Marchetto D. J., Tsai S., Jacobs S. C., Brown R. S. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med. 1979 Sep 13;301(11):592–595. doi: 10.1056/NEJM197909133011107. [DOI] [PubMed] [Google Scholar]
  9. Erisman M. D., Rothberg P. G., Diehl R. E., Morse C. C., Spandorfer J. M., Astrin S. M. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol. 1985 Aug;5(8):1969–1976. doi: 10.1128/mcb.5.8.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  11. Fishel R., Lescoe M. K., Rao M. R., Copeland N. G., Jenkins N. A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993 Dec 3;75(5):1027–1038. doi: 10.1016/0092-8674(93)90546-3. [DOI] [PubMed] [Google Scholar]
  12. Fong K. M., Biesterveld E. J., Virmani A., Wistuba I., Sekido Y., Bader S. A., Ahmadian M., Ong S. T., Rassool F. V., Zimmerman P. V. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res. 1997 Jun 1;57(11):2256–2267. [PubMed] [Google Scholar]
  13. Gemma A., Hagiwara K., Ke Y., Burke L. M., Khan M. A., Nagashima M., Bennett W. P., Harris C. C. FHIT mutations in human primary gastric cancer. Cancer Res. 1997 Apr 15;57(8):1435–1437. [PubMed] [Google Scholar]
  14. Greenspan D. L., Connolly D. C., Wu R., Lei R. Y., Vogelstein J. T., Kim Y. T., Mok J. E., Muñoz N., Bosch F. X., Shah K. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res. 1997 Nov 1;57(21):4692–4698. [PubMed] [Google Scholar]
  15. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991 Aug 9;66(3):589–600. doi: 10.1016/0092-8674(81)90021-0. [DOI] [PubMed] [Google Scholar]
  16. Hendricks D. T., Taylor R., Reed M., Birrer M. J. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res. 1997 Jun 1;57(11):2112–2115. [PubMed] [Google Scholar]
  17. Huang Y., Garrison P. N., Barnes L. D. Cloning of the Schizosaccharomyces pombe gene encoding diadenosine 5',5"'-P1,P4-tetraphosphate (Ap4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family. Biochem J. 1995 Dec 15;312(Pt 3):925–932. doi: 10.1042/bj3120925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Huebner K., Garrison P. N., Barnes L. D., Croce C. M. The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet. 1998;32:7–31. doi: 10.1146/annurev.genet.32.1.7. [DOI] [PubMed] [Google Scholar]
  19. Kapp L. N., Painter R. B., Yu L. C., van Loon N., Richard C. W., 3rd, James M. R., Cox D. R., Murnane J. P. Cloning of a candidate gene for ataxia-telangiectasia group D. Am J Hum Genet. 1992 Jul;51(1):45–54. [PMC free article] [PubMed] [Google Scholar]
  20. Knudson A. G., Jr Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985 Apr;45(4):1437–1443. [PubMed] [Google Scholar]
  21. Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984 Jan 25;12(2):857–872. doi: 10.1093/nar/12.2.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lima C. D., D'Amico K. L., Naday I., Rosenbaum G., Westbrook E. M., Hendrickson W. A. MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family. Structure. 1997 Jun 15;5(6):763–774. doi: 10.1016/s0969-2126(97)00231-1. [DOI] [PubMed] [Google Scholar]
  23. Lima C. D., Klein M. G., Weinstein I. B., Hendrickson W. A. Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5357–5362. doi: 10.1073/pnas.93.11.5357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Michael D., Beer D. G., Wilke C. W., Miller D. E., Glover T. W. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene. 1997 Oct 2;15(14):1653–1659. doi: 10.1038/sj.onc.1201330. [DOI] [PubMed] [Google Scholar]
  25. Murphree A. L., Benedict W. F. Retinoblastoma: clues to human oncogenesis. Science. 1984 Mar 9;223(4640):1028–1033. doi: 10.1126/science.6320372. [DOI] [PubMed] [Google Scholar]
  26. Ohta M., Inoue H., Cotticelli M. G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996 Feb 23;84(4):587–597. doi: 10.1016/s0092-8674(00)81034-x. [DOI] [PubMed] [Google Scholar]
  27. Pearson J. D., DeWald D. B., Mathews W. R., Mozier N. M., Zürcher-Neely H. A., Heinrikson R. L., Morris M. A., McCubbin W. D., McDonald J. R., Fraser E. D. Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem. 1990 Mar 15;265(8):4583–4591. [PubMed] [Google Scholar]
  28. Russell J. E., Morales J., Makeyev A. V., Liebhaber S. A. Sequence divergence in the 3' untranslated regions of human zeta- and alpha-globin mRNAs mediates a difference in their stabilities and contributes to efficient alpha-to-zeta gene development switching. Mol Cell Biol. 1998 Apr;18(4):2173–2183. doi: 10.1128/mcb.18.4.2173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Simon B., Bartsch D., Barth P., Prasnikar N., Münch K., Blum A., Arnold R., Göke B. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Cancer Res. 1998 Apr 15;58(8):1583–1587. [PubMed] [Google Scholar]
  30. Siprashvili Z., Sozzi G., Barnes L. D., McCue P., Robinson A. K., Eryomin V., Sard L., Tagliabue E., Greco A., Fusetti L. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13771–13776. doi: 10.1073/pnas.94.25.13771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sozzi G., Alder H., Tornielli S., Corletto V., Baffa R., Veronese M. L., Negrini M., Pilotti S., Pierotti M. A., Huebner K. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res. 1996 Jun 1;56(11):2472–2474. [PubMed] [Google Scholar]
  32. Sozzi G., Veronese M. L., Negrini M., Baffa R., Cotticelli M. G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell. 1996 Apr 5;85(1):17–26. doi: 10.1016/s0092-8674(00)81078-8. [DOI] [PubMed] [Google Scholar]
  33. Su T. H., Wang J. C., Tseng H. H., Chang C. P., Chang T. A., Wei H. J., Chang J. G. Analysis of FHIT transcripts in cervical and endometrial cancers. Int J Cancer. 1998 Apr 13;76(2):216–222. doi: 10.1002/(sici)1097-0215(19980413)76:2<216::aid-ijc8>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  34. Thiagalingam S., Lisitsyn N. A., Hamaguchi M., Wigler M. H., Willson J. K., Markowitz S. D., Leach F. S., Kinzler K. W., Vogelstein B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res. 1996 Jul 1;56(13):2936–2939. [PubMed] [Google Scholar]
  35. Turnbull R. B., Jr, Kyle K., Watson F. R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. doi: 10.1097/00000658-196709000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wang N., Perkins K. L. Involvement of band 3p14 in t(3;8) hereditary renal carcinoma. Cancer Genet Cytogenet. 1984 Apr;11(4):479–481. doi: 10.1016/0165-4608(84)90028-1. [DOI] [PubMed] [Google Scholar]
  37. Zehner Z. E., Shepherd R. K., Gabryszuk J., Fu T. F., Al-Ali M., Holmes W. M. RNA-protein interactions within the 3 ' untranslated region of vimentin mRNA. Nucleic Acids Res. 1997 Aug 15;25(16):3362–3370. doi: 10.1093/nar/25.16.3362. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES